Results 341 to 350 of about 789,387 (385)
Some of the next articles are maybe not open access.
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
New England Journal of MedicineBACKGROUND Colorectal cancer is the third most diagnosed cancer in adults in the United States. Early detection could prevent more than 90% of colorectal cancer-related deaths, yet more than one third of the screening-eligible population is not up to ...
Daniel C. Chung+12 more
semanticscholar +1 more source
Science Translational Medicine, 2020
Circulating tumor DNA methylation–based signatures are potential biomarkers for early diagnosis and prognosis of colorectal cancer. Methylation marks the spot The detection of circulating tumor DNA in the blood is a noninvasive method that may help ...
Hui‐yan Luo+23 more
semanticscholar +1 more source
Circulating tumor DNA methylation–based signatures are potential biomarkers for early diagnosis and prognosis of colorectal cancer. Methylation marks the spot The detection of circulating tumor DNA in the blood is a noninvasive method that may help ...
Hui‐yan Luo+23 more
semanticscholar +1 more source
Clinical Update, 2007
Commentary In the last few years, we have seen a surge in referrals for colonoscopy because of an increase in public and physician awareness of the need for colorectal cancer (CRC) screening. Colonoscopy has become one of the most important screening tools for CRC, because it can provide diagnosis and treatment in 1 visit.
openaire +4 more sources
Commentary In the last few years, we have seen a surge in referrals for colonoscopy because of an increase in public and physician awareness of the need for colorectal cancer (CRC) screening. Colonoscopy has become one of the most important screening tools for CRC, because it can provide diagnosis and treatment in 1 visit.
openaire +4 more sources
Screening for Colorectal Cancer
Gastroenterology Clinics of North America, 2008This paper reviews studies on fecal occult blood testing and sigmoidoscopy screening for colorectal cancer. Recently published data from a randomized controlled trial provides the first concrete evidence that annual screening for fecal occult blood can reduce colorectal cancer mortality by at least 33%. These results are corroborated by a nonrandomized
openaire +4 more sources
Cancer and Metastasis Reviews, 1997
Colorectal cancer occurs throughout the world. Little is known about the etiology of this disease, however, adequate data exist to recommend secondary prevention with mass screening of average risk asymptomatic people age 50 or over. Three randomized controlled trials of a guaiac test for fecal occult blood involving over 250,000 participants found ...
openaire +3 more sources
Colorectal cancer occurs throughout the world. Little is known about the etiology of this disease, however, adequate data exist to recommend secondary prevention with mass screening of average risk asymptomatic people age 50 or over. Three randomized controlled trials of a guaiac test for fecal occult blood involving over 250,000 participants found ...
openaire +3 more sources
Screening for Colorectal Cancer
New England Journal of Medicine, 2002Colorectal cancer screening can prevent the development of colorectal cancer and reduce the risk for death. Screening recommendations include fecal occult blood testing, sigmoidoscopy, radiographic imaging of the colon, and colonoscopy. This article focuses on recommendations for average-risk individuals and discusses the potential benefits and ...
openaire +4 more sources
Screening for Colorectal Cancer [PDF]
A healthy 76-year-old woman presents as a new patient for primary care. She reports having one daily bowel movement and no rectal bleeding. She has no family history of colorectal cancer. She reports having negative stool-card tests during gynecologic examinations, most recently at 65 years of age.
openaire +2 more sources
Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
Gastroenterology, 2020BACKGROUND & AIMS Recommendation of surveillance colonoscopy should be based on risk of colorectal cancer and death after adenoma removal. We aimed to develop risk classification system based on colorectal cancer incidence and mortality following adenoma
P. Wieszczy+14 more
semanticscholar +1 more source
Participation and yield of a population-based colorectal cancer screening programme in China
Gut, 2018Objective Colorectal cancer (CRC) screening has been widely implemented in many countries. However, evidence on participation and diagnostic yield of population-based CRC screening in China is sparse.
Hongda Chen+15 more
semanticscholar +1 more source
Screening for colorectal cancer
Seminars in Oncology, 2017This review will comprise a general overview of colorectal cancer (CRC) screening. We will cover the impact of CRC, CRC risk factors, screening modalities, and guideline recommendations for screening in average-risk and high-risk individuals. Based on this data, we will summarize our approach to CRC screening.
Rosalyn W. Stewart+3 more
openaire +3 more sources